FDA Infants taking Proglycem Warning
The Risk Of Proglycem to Children. Proglycem, a drug used to treat low blood sugar, has been associated with reports of pulmonary hypertension in infants and newborns taking the medication, the U.S. Food and Drug Administration (FDA) warned. Pulmonary hypertension is a serious lung condition where there is high blood pressure in … [Read more...] about FDA Infants taking Proglycem Warning
No Conclusion From FDA on Possible SSRI Antidepressant
FDA can't Answer the Question Taking SSRI during Pregnancy. The U.S. Food & Drug Administration (FDA) still can't answer the question of whether taking selective serotonin reuptake inhibitor (SSRI) antidepressants during pregnancy may increase the risk that a baby will be born with pulmonary hypertension of the newborn … [Read more...] about No Conclusion From FDA on Possible SSRI Antidepressant
